The estimated Net Worth of Paul Colvin is at least 3.92 百万$ dollars as of 1 February 2021. Mr. Colvin owns over 8,486 units of Syneos Health Inc stock worth over 1,215,260$ and over the last 5 years he sold SYNH stock worth over 634,923$. In addition, he makes 2,067,720$ as President - Clinical Solutions at Syneos Health Inc.
Sign up
Mr. Colvin SYNH stock SEC Form 4 insiders trading
Paul has made over 2 trades of the Syneos Health Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 8,486 units of SYNH stock worth 634,923$ on 1 February 2021.
The largest trade he's ever made was selling 8,486 units of Syneos Health Inc stock on 1 February 2021 worth over 634,923$. On average, Paul trades about 979 units every 32 days since 2020. As of 1 February 2021 he still owns at least 28,275 units of Syneos Health Inc stock.
You can see the complete history of Mr. Colvin stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Paul Colvin biography
Paul D. Colvin serves as President - Clinical Solutions of the Company. He has been our President, Clinical Solutions since December 2018. Prior to joining Syneos Health, Mr. Colvin held multiple leadership roles at PPD, a leading global CRO, from October 2007 to December 2018. From May 2010 to June 2016, Mr. Colvin served as Executive Vice President, Global Clinical Development, PPD. Mr. Colvin also served as Chairman and CEO of PPD-SNBL, a joint venture that grew to be one of the largest clinical development service providers in Japan, from December 2014 to December 2018. Mr. Colvin served as Executive Vice President, Biopharma Partnerships, PPD from June 2016 to December 2018. Prior to joining PPD, Mr. Colvin held various leadership positions at Eli Lilly and Company, a global pharmaceutical company, from January 1993 to October 2007. He received his Bachelor of Science in Pharmacy from Butler University. He is also a registered pharmacist and completed executive development programs at London Business School and the Center for Creative Leadership.
What is the salary of Paul Colvin?
As the President - Clinical Solutions of Syneos Health Inc, the total compensation of Paul Colvin at Syneos Health Inc is 2,067,720$. There are 2 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of 7,646,360$.
How old is Paul Colvin?
Paul Colvin is 50, he's been the President - Clinical Solutions of Syneos Health Inc since 2019. There are 11 older and 7 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
What's Paul Colvin's mailing address?
Paul's mailing address filed with the SEC is C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE, NC, 27560.
Insiders trading at Syneos Health Inc
Over the last 7 years, insiders at Syneos Health Inc have traded over 16,280,601,287$ worth of Syneos Health Inc stock and bought 17,946 units worth 873,496$ . The most active insiders traders include Todd M Abbrecht、John L. Maldonado、Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of 83,067,962$. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth 117,156$.
What does Syneos Health Inc do?
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
What does Syneos Health Inc's logo look like?
Complete history of Mr. Colvin stock trades at Syneos Health Inc
Syneos Health Inc executives and stock owners
Syneos Health Inc executives and other stock owners filed with the SEC include:
-
Alistair Macdonald,
Chief Executive Officer, Director -
Jason Meggs,
Chief Financial Officer -
Paul Colvin,
President - Clinical Solutions -
Michelle Keefe,
President - Commercial Solutions -
Jonathan Olefson,
General Counsel, Corporate Secretary -
Alistair Macdonald,
CEO & Director -
Jason M. Meggs,
Chief Financial Officer -
Paul D. Colvin,
Chief Bus. Officer -
Michelle Keefe,
Pres of Commercial Solutions -
Jonathan Olefson,
Gen. Counsel & Corp. Sec. -
John Dineen,
Independent Chairman of the Board -
William Klitgaard,
Independent Director -
Kenneth Meyers,
Independent Director -
Linda Harty,
Independent Director -
Matthew Monaghan,
Independent Director -
Joshua Nelson,
Independent Director -
Todd Abbrecht,
Independent Director -
Bernadette Connaughton,
Independent Director -
Thomas Allen,
Independent Director -
John Maldonado,
Independent Director -
Ronnie Speight,
Senior Vice President, Investor Relations -
Robert Parks,
Executive Vice President, Chief Accounting Officer -
Lisa van Capelle,
Chief Human Resource Officer -
Dr. Judith Ng-Cashin M.D.,
Chief Scientific Officer -
Kristen Spensieri,
Global Head of Corp. Communications & Marketing -
Larry A. Pickett Jr.,
Chief Information & Digital Officer -
Dr. Judith Ng-Cashin,
Chief Scientific Officer -
Donna Hildebrand Kralowetz,
Sr. VP of Fin. & Principal Accounting Officer -
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Ma Doubl...,
-
Tom Allen,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Christopher L Gaenzle,
CAO, GC & Sec -
Michael Adam Bell,
Director -
Joshua M Nelson,
-
Todd M Abbrecht,
-
H. Lee Advisors, Llcthl Hol...,
-
H. Lee Advisors, Llc Thomas...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llc Thomas...,
-
H. Lee Advisors, Llcthl Fun...,
-
H. Lee Equity Fund Vi, L.P....,
-
Christian Tucat,
Chief Business Officer -
Michael Lee Brooks,
Chief Operating Officer -
Barbara W. Bodem,
Director -
Alfonso G Zulueta,
Director -
Stanford Rudnick,
See remarks -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Michael J. Bonello,
Chief Financial Officer -
Donna Hildebrand Kralowetz,
EVP, Chief Accounting Officer -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Maap Gpe...,
-
David S. Wilkes,
Director